Lepu Biopharma Co. Ltd. Class H (HK:2157) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Lepu Biopharma Co., Ltd. has entered into a CDMO Services Framework Agreement with Lepu Medical, aiming to provide technical services and equipment for GLP-1 and related products. As a connected transaction, it requires approval from independent shareholders and is subject to specific reporting and review requirements. An Extraordinary General Meeting will be held to consider and approve this agreement.
For further insights into HK:2157 stock, check out TipRanks’ Stock Analysis page.